When doctors and other types of providers provide pretest genetic testing education to patients, it allows Clearview's ...

Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating ...

Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while considering patient preferences and treatment goals.

Through a new partnership, Caris will use its comprehensive genomic profiling tests to sequence more than 10,000 early-stage breast tumors collected in TAILORx.

The combined company, which will be called Opus Genetics, will focus on advancing a pipeline of gene therapies for inherited retinal diseases.

After meeting with the agency, the firm is optimistic it can submit a BLA for isaralgagene civaparvovec in the second half of 2025 using an intermediate endpoint.

The firm will use to funds to validate its CD123-targeted CAR T-cell therapies in acute myeloid leukemia in clinical studies.